0
Abstract: Poster Presentations |

SUCCESS OF ONE-TIME SMOKING CESSATION COUNSELING FREE TO VIEW

C. T. Vo, BS; C. M. Kirsch, MD; E. I. Hsiao, MD; J. H. Wehner, MD*; V. Mohindra, MD; F. T. Kagawa, MD; W. A. Jensen, MD
Author and Funding Information

Santa Clara Valley Medical Center, San Jose, CA


Chest


Chest. 2007;132(4_MeetingAbstracts):527b. doi:10.1378/chest.132.4_MeetingAbstracts.527b
Text Size: A A A
Published online

Abstract

PURPOSE: Smoking is responsible for many leading causes of morbidity and death in the United States. An understanding of relapse rates after smoking cessation counseling may help identify when re-intervention should be done. Staying Free (SF), a smoking cessation program, offers a one-time individualized bedside consultation followed by 5 post-discharge telephone contacts at 2, 7, 21, 90 and 180 days to all actively smoking inpatients.

METHODS: Over a 3 year period, the smoking status of 598 patients (367 men and 231 women) was analyzed to evaluate relapses at each follow-up time point. Cochran's Q test was used to determine significant differences in smoking status at each period, and P≤;0.05 was considered statistically significant. The results are reported as percentages of nonsmokers ± SEM.

RESULTS: The percentage of discharged smokers who remained smoke-free was 54% ± 0.02 at 2 days, 44% ± 0.02 at 7 days, 39% ± 0.02 at 21 days, 29% ± 0.02 at 90 days and 31% ± 0.02 at 180 days. The proportion of nonsmokers significantly decreased at each subsequent time point from 2 days to 90 days after hospital discharge (P≤;0.01). There was no significance in smoking relapse between 90 and 180 days (P=0.325).

CONCLUSION: We conclude that the proportion of patients who remain smoke-free decreases progressively over the first 90 days after one-time smoking cessation counseling. The risk of further smoking relapse, beyond the first 90 days, may not be significant.

CLINICAL IMPLICATIONS: Implementation of additional smoking cessation support within the first 90 days after hospital discharge may prevent early relapses.

DISCLOSURE: J. Wehner, No Financial Disclosure Information; No Product/Research Disclosure Information

Wednesday, October 24, 2007

12:30 PM - 2:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
Guidelines
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543